William Blair just gave Vertex Pharmaceuticals a shiny bump in its 2025 earnings forecast, increasing EPS to $16.20 from ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...

Solar financing platform Metafin has raised $10 million in a Series A funding round led by Vertex Ventures Southeast Asia and India. Subscribe now to enjoy unlimited access at just $59. Premium ...

The market expects Vertex Pharmaceuticals (VRTX) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known ...

With a market cap of $122.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) operates as a global biotechnology company that develops and commercializes therapies for treating cystic fibrosis (CF).

She reiterated her buy recommendation on Vertex stock, and kept her $583-per-share price target intact. According to reports, Merle's update was based on surveys with medical professionals ...

Eli Lilly should be appealing to both growth and income investors. Vertex has a virtual monopoly in treating CF and multiple growth drivers. When the stock market is highly volatile, many ...

Gainesville police officers are searching for a suspect who allegedly shot three people Sunday night at an Easter egg hunt held in TB McPherson Park. According to a Gainesville Police Department (GPD) ...